RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML

https://doi.org/10.1016/j.celrep.2017.05.005 23rd May 2017

Article highlights & insights

Acute myeloid leukaemia (AML) is a heterogeneous disease caused by mutations in transcriptional regulator genes, but how different mutant regulators shape the chromatin landscape is unclear.

Here, Loke et al compared the transcriptional networks of two types of AML with chromosomal translocations of the RUNX1 locus that fuse the RUNX1 DNA-binding domain to different regulators, the t(8;21) expressing RUNX1-ETO and the t(3;21) expressing RUNX1-EVI1. Despite containing the same DNA-binding domain, the two fusion proteins display distinct binding patterns, show differences in gene expression and chromatin landscape, and are dependent on different transcription factors.

RUNX1-EVI1 directs a stem cell-like transcriptional network reliant on GATA2, whereas that of RUNX1-ETO-expressing cells is more mature and depends on RUNX1. However, both types of AML are dependent on the continuous expression of the fusion proteins.

This data provides a molecular explanation for the differences in clinical prognosis for these types of AML.

Four individuals pose together in a laboratory. They're wearing lab coats each with a Cancer Research UK logo.
An immunofluorescence microscopy image of kidney tissue showing different tissue structures stained in red, blue, and green The blue colour (DAPI) is widespread, indicating the location of cell nuclei throughout the sample. The green colour (LTL) highlights specific regions, indicating the presence of proximal tubule cells. The red colour (NPHS1) is also distinct in certain areas, showing the presence of podocytes in the glomeruli. The overlapping colours in some regions suggest the complex structure and the close association of these different cell types within the kidney.

Latest from CRUK MI

New major support for our lung cancer prevention research

ScottishPower has committed £690,000 to co-fund our Cancer Origins research group with the University of Manchester, enabling investigations into what causes lung cancer to emerge and how we can prevent it.

New publication: Bacteria inside kidney tumors associate with myeloid inflammation and disease progression – A TRACERx Renal study

Research explores the role of intratumour bacteria in disease progression

Read our latest Scientific Report

The latest Scientific Report highlights an incredible year of growth for the Institute and many research successes. We welcomed a new Director, Samra Turajlić to the Institute, and saw the establishment of three new independent research groups.

New major support for our lung cancer prevention research
New publication: Bacteria inside kidney tumors associate with myeloid inflammation and disease progression – A TRACERx Renal study
Read our latest Scientific Report